NewsRx

Search our medical news database

Breast Cancer

Circulating tumor cells predict survival in metastatic disease, data confirm

Published in Cancer Weekly, June 7th, 2005

Longer-term data on patients with metastatic breast cancer have further validated the predictive importance of circulating tumor cells (CTCs) in blood.

Findings presented at the annual meeting of the American Society of Clinical Oncology expand on data previously reported in The New England Journal of Medicine (2004;351(8):781-791), according to Veridex, LLC.

Of the 177 patients in the study, 53% of women with five or more CTCs per 7.5 mL of blood prior to therapy were found not to survive a year after initial diagnosis, versus 19% whose blood indicated fewer than five CTCs at the same point. Patients in the study were either about to start...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook